Equity Vaccines prepares to launch clinical trials for groundbreaking malaria vaccine in Nigeria
Equity Vaccines Ltd., a pioneering subsidiary of the Equity Health Group, is on the verge of completing the pre-clinical stage of its innovative malaria vaccine in collaboration with a reputable university in Nigeria. This significant achievement sets the stage for
by Guardian Nigeria
Read More